Market Tracker

08/17 7:12am ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

10.60
Delayed Data
As of Aug 16
 -0.60 / -5.36%
Today’s Change
2.65
Today|||52-Week Range
12.05
+247.54%
Year-to-Date

Today’s Trading

Previous close11.20
Today’s open11.25
Day’s range10.30 - 11.55
Volume2,124,658
Average volume (3 months)1,449,747
Market cap$936.4M
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)+15.40%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book5.83

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+0.77+3.42%
EDITEditas Medicine Inc+0.09+0.44%
NDRMNeuroderm Ltd+0.05+0.13%
FPRXFive Prime Therapeut...+0.75+2.70%
Data as of 08/16/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts